Light-Activated Gene Editing with a Photocaged Zinc-Finger Nuclease
Light-Activated Gene Editing with a Photocaged Zinc-Finger Nuclease
复制标题
DOI:
10.1002/anie.201101157
复制
发表时间:
2011-01-01
影响因子:
16.6
通讯作者:
Deiters, Alexander
中科院分区:
文献类型:
--
作者:
Chou, Chungjung;Deiters, Alexander
A general approach for targeted gene modification with precise external control and high spatial and temporal resolution will greatly advance investigations in genetics, gene therapy, and developmental biology. However, traditional methods such as homologous recombination [1] and nonhomologous end joining [2] for the introduction and deletion of genomic DNA sequences usually display very low efficiency in vivo, thus limiting their applicability. Recently, the efficiency of these processes has been greatly improved by the ability to site-specifically introduce doublestrand breaks (DSBs) into genomic DNA.[3, 4] A family of artificial restriction enzymes, namely zinc-finger nucleases (ZFN), has been developed to sequence-selectively achieve dsDNA scission. ZFNs have since emerged as important and widely recognized tools for the genetic modification of cells, model organisms, and possibly humans to investigate gene function and to treat genetic disorders.[5–9]Structurally, a ZFN is a chimeric protein containing two domains: an N-terminal zinc-finger domain and a C-terminal nuclease domain. The N-terminal zinc-finger domain usually consists of three to four Cys2His2 “fingers”.[10–13] Each finger recognizes three DNA basepairs through hydrogen-bonding interactions in the major groove of the DNA. The binding specificities of these fingers to certain DNA sequences can be engineered by selection [14] or modular assembly [15] and subsequent in vivo testing.[16] The C-terminal nuclease domain was evolved from the type IIS restriction enzyme FokI [17] and is dimerized in a tail-to-tail conformation with a second ZFN to introduce a DSB between two recognition sites. ZFN heterodimers recognize a 24 bp composite DNA site which statistically guarantees single occurrence in the genome of targeted cells and organisms.[6]